SOST and osteoporosis: Therefore, the results of this study were in accordance with previous studies showing that there was a negative association between sclerostin and BMD and echoed the studies using agents antagonizing the effects of sclerostin to increased BMD and to prevent osteoporosis in post-menopausal women [31,32,33].